(MRN) complex. Here we show that, in human and mouse, Mre11 controls these events through a direct interaction with CDK2 that is required for CtIP phosphorylation and BRCA1 interaction in normally dividing cells. CDK2 binds the C terminus of Mre11, which is absent in an inherited allele causing ataxia telangiectasia-like disorder. This newly uncovered role for Mre11 does not require ATM activation or nuclease activities. Therefore, functions of MRN are not restricted to DNA damage responses but include regulating homologous recombination capacity during the normal mammalian cell cycle. npg
a r t i c l e s Maintenance of genome stability is of crucial importance to cellular and organismal survival. Double-strand breaks (DSBs) are highly toxic legions that can lead to loss or amplification of genetic information, chromosomal translocations, neoplastic transformation and cell death 1 . To counteract these lesions and mitigate their consequences, cells activate a complex network of repair and signaling pathways, collectively known as the DNA damage response (DDR) 2 . The DDR coordinates diverse processes such as cell-cycle checkpoint signaling cascades, localized chromatin modifications and functions of multiprotein DNA repair complexes. Individuals born with a defective DDR have syndromes with diverse sequelae, including cancer predisposition, neurodegeneration and immunodeficiency 3 .
The homologous recombination pathway facilitates highly accurate DSB repair by using homologous sequences on the sister chromatid as a replication template during repair 4 . Because of the need for a sister chromatid to be present, homologous recombination has a limited role in G1 and is the predominant pathway during S and G2 phases of the cell cycle. Recent evidence supports the notion that this is achieved through active control of the capacity to catalyze homologous recombination throughout the cell cycle. This active control takes place at the initiation step of homologous recombination, which entails nucleolytic resection of the DSB ends to generate single-stranded DNA with 3′ termini 5 . These termini subsequently serve to prime replication after strand invasion of the intact homologous duplex 4 .
In mammals, resection to initiate homologous recombination depends upon the Mre11-Rad50-NBS1 (MRN) complex [6] [7] [8] [9] . MRN is a versatile protein complex that has multiple roles in the DDR, including direct functions in repair as well as initiation of signaling cascades 10 . The core of MRN consists of a highly conserved Mre11-Rad50 heterotetramer that binds one or both sides of the DSB 11, 12 . Once bound, coiled-coil arms of Rad50 stabilize the break over long distances 13 , followed by close-range stabilization by an Mre11 dimer 12 . Within this dimer, Mre11 provides nuclease activities required to initiate resection 6, 12, 14 . The less conserved NBS1 subunit interacts with the ATM kinase, considered the primary signal transducer of the DDR 15 . Upon binding a DSB, structural alterations are transmitted through the MRN complex, leading to activation of ATM [16] [17] [18] .
Although required, the nuclease activities of Mre11 alone are not sufficient for resection. This requires the BRCA1 tumor suppressor and the CtIP protein, both bound to MRN 9, 19, 20 . CtIP shares a limited region of homology with the Sae2 nuclease in Saccharomyces cerevisiae 9 , but unlike Sae2, CtIP has not yet been shown to possess nuclease activities. Rather, CtIP interaction appears to be required to enhance Mre11 nuclease activity 9, 21 . For efficient resection in vivo, CtIP must interact with BRCA1 (refs. 19, 20) . It is the formation and dissolution of the MRN-CtIP-BRCA1 complex that provides the regulation of resection capacity (and thus homologous recombination capacity) throughout the cell cycle 19, 20 . This complex is only found in S and G2 phases (ref. 20) .
In mammals, CtIP is the primary factor responsible for cell-cycle regulation of resection 19, 20, 22 . This is accomplished by two types of cell-phase-specific post-translational modifications of CtIP. First, CtIP protein levels are suppressed in G1 by proteasome-mediated degradation, which is alleviated as cells enter S phase, thereby permitting a rise in protein levels 23 . Second, CtIP is a substrate for S-phase-specific CDK activity 19, 22, 24 . This phosphorylation is required for assembly of the MRN-CtIP-BRCA1 resection complex 20, 22 .
Phosphorylation of CtIP by S-phase CDK provides a direct linkage between DNA resection capacity and the core cell-cycle machinery 25 . CDKs are a family of serine/threonine protein kinases that are regulated by binding to their cyclin partners and by posttranslational modifications and other interactions 26 . CtIP contains a r t i c l e s two well-conserved CDK phosphorylation sites: Ser327, which is phosphorylated as cells enter S phase and is necessary for interaction with BRCA1 (refs. 19, 20, 24) , and Thr847, which is located in the Sae2 homology region and is necessary for localization of CtIP to DSBs 9, 22, 27 . Phosphomimetic modification of the Thr847 site leads to hyperactivation of resection and increased genome instability 22 . In mammals, the primary active CDK in S phase is CDK2 bound to cyclin A 26 . Consistent with a role in controlling CtIP, deficiency of CDK2 in mammalian cells has been shown to confer a defect in homologous recombination 28, 29 .
It is now apparent that eukaryotes have two overall strategies for managing the threat of DSBs. These are represented by the canonical DDR after damage occurs and also by the regulation of repair capacity through interfacing the DNA repair and core cell-cycle machineries. Although the DDR itself has been studied extensively, comparatively little is known about CDK-dependent regulation of the DSB repair machinery. Hence, what factors govern preparation for damage and what their relationship is to DNA damage responses are questions of fundamental importance. To gain understanding of the regulation of homologous recombination capacity and how CDK activity is involved, we investigated the relationship between CtIP and the MRN complex. We discovered that the Mre11 component of MRN has a crucial role in regulating resection and the capacity for homologous recombination independently of previously characterized roles in the DDR.
RESULTS

CtIP protein levels are reduced in Mre11 deficient cells
Ataxia telangiectasia-like disorder (ATLD) features cerebellar degeneration leading to ataxia, as well as genomic instability and hypersensitivity to agents that cause DSBs. This syndrome results from inherited recessive hypomorphic alleles of Mre11 (ref. 30) . Mre11 ATLD1 is a nonsense mutation that truncates 78 amino acids from the C terminus and causes very low levels of all three MRN components 30, 31 . Given the relationship between MRN and CtIP, we determined if CtIP levels are affected in this disorder. Indeed, CtIP levels are depleted in cells derived from a person with ATLD or from a mouse model expressing only Mre11 ATLD1 (Fig. 1a) . Ataxia telangiectasia is a disorder similar to ATLD and results from inherited mutation in the ATM gene 32 . Despite similar clinical outcomes and cellular phenotypes of the disorders, we find that ATM deficiency does not affect CtIP levels ( Fig. 1a) .
To further examine the MRN-CtIP relationship, we used murine cells harboring loxP-flanked (floxed) conditional allele of Mre11 (Mre11 cond/− ) in which RAD50 and NBS1 protein levels are reduced when Mre11 is rendered deficient (Mre11 −/− ) ( Supplementary  Fig. 1 ) 6 . In MRN-deficient cells (Mre11 −/− ), CtIP protein levels were markedly reduced ( Supplementary Fig. 2) . By contrast, BRCA1 levels were unaffected. CtIP levels were also assessed in murine cells expressing Mre11 H129N (Mre11 H129N/− ) ( Supplementary Fig. 1 ), a targeted germline missense mutation causing defective Mre11 nuclease activities while preserving integrity of the MRN complex 6 . No effect on CtIP levels was observed in these cells ( Supplementary Fig. 2) .
The tight regulation of CtIP throughout the cell cycle raises the possibility that low CtIP levels could result from populations of cells arrested outside of the S or G2 phase. However, prior work on cells harboring the Mre11 −/− murine knockout or a variety of other spontaneous or engineered MRN mutations has demonstrated that MRN deficiency does not cause a substantial arrest during the cell cycle 6, 7, 31, 33, 34 . Rather, these cells proliferate more slowly than the control does, but all phases of the cell cycle are equally represented. To further address this concern, we examined CtIP levels in cells synchronized by release from serum starvation. Cell-cycle progression was tracked by the appearance of cyclin A, which is specific to S or G2. Upon release, cyclin A became readily detectable in control (Mre11 +/− ), MRN-deficient (Mre11 −/− ) and Mre11 nuclease-deficient npg a r t i c l e s (Mre11 H129N/− ) populations ( Fig. 1b) . CtIP was clearly deficient in Mre11 −/− cells throughout the time course, including at points with maximal cyclin A levels (S or G2 populations) ( Fig. 1b) . Thus, in mammals, CtIP levels appear to be under control of the MRN complex. This hitherto unknown role for MRN is independent of Mre11 nuclease activities and the ATM kinase.
CtIP protein levels depend on the Mre11 C terminus
We engineered a system in which full-length Mre11 cDNA is stably expressed from an integrated plasmid vector in cells that were Mre11 cond/− . Endogenous Mre11 was subsequently removed through Cre-mediated conversion of Mre11 cond/− to Mre11 −/− , and independent clones with Mre11 levels similar to endogenous were pursued for further study (Supplementary Fig. 3 ). Mre11 expressed from cDNA successfully reconstituted levels of Rad50 and NBS1 ( Fig. 1c) and supported the ability of MRN to activate the ATM kinase, as determined by relative levels of ATM autophosphorylation ( Fig. 1d) 15, 35 . Unexpectedly, despite the apparent restoration of MRN, CtIP protein levels were not restored ( Fig. 1c) . This suggests that the mechanisms by which Mre11 influences CtIP levels as compared to RAD50 or NBS1 levels are distinct.
The expression system fused 54 amino acids to the Mre11 C terminus (hereafter termed Mre11 C54 ), originating from three tags (His-V5-His). To test the possibility that this large addition prevents CtIP restoration, we reconstructed the plasmid to express Mre11 fused only to a short histidine tag composed of five amino acids (Mre11 C5 ). Indeed, Mre11 C5 expression restored CtIP (Fig. 1c) . Thus, we hypothesized that the C terminus of Mre11 possesses an unknown function that controls CtIP levels. We therefore examined the impact of Mre11 ATLD1 C-terminal deletion. Existing ATLD1 cell lines cannot be used to study specific roles of the Mre11 C terminus, as they also harbor low levels of the entire MRN complex 30, 31 . To circumvent this limitation, we stably expressed Mre11 ATLD1 from cDNA in Mre11 −/− cells (Fig. 1c) . When expressed to approximately endogenous levels, Mre11 ATLD1 showed a pattern identical to the impact of Mre11 C54 and restored NBS1 and Rad50 levels and ATM activation without restoration of CtIP ( Fig. 1c,d) .
Thus, the C terminus of Mre11 possesses a distinct function required to maintain normal CtIP levels.
Mre11 controls CtIP phosphorylation status
The dependence of CtIP on MRN might simply reflect the need for proper interactions to maintain protein levels, as is presumed to be the case for the mutual dependence among the three MRN components 6, 36 . However, the cell-cycle regulation of CtIP levels is distinct from MRN and raises the specter of a more complex relationship. CtIP levels are suppressed in G1 through proteasome-mediated degradation 23 , hence we explored whether proteasome inhibition could reveal aspects of the relationship between CtIP and MRN. We treated cells with the proteasome inhibitor MG-132 and observed that CtIP levels were restored in Mre11 −/− cells ( Fig. 2a) . Notably, proteasome inhibition did not restore Nbs1 levels ( Fig. 2a) . Thus, physical association with MRN is not required to maintain CtIP levels.
The return of CtIP to measurable levels by proteasome inhibition permitted further characterization of the protein in the absence of the Mre11 C terminus. We used phage lambda phosphatase to analyze the phosphorylation status of CtIP in normally dividing cells. In control cells, most detectable CtIP was phosphorylated, and proteasome inhibition had no detectable effect ( Fig. 2b) . By contrast, CtIP was clearly hypophosphorylated in the absence of MRN (Mre11 −/− ) or of the Mre11 C terminus (Mre11 ATLD1 ). Because CDK-dependent phosphorylation of CtIP is required for interaction with BRCA1 (refs. 19, 20, 24) , we carried out coimmunoprecipitation experiments to assess CtIP-BRCA1 interaction in cells lacking the Mre11 C terminus. Indeed, BRCA1-CtIP interaction is disrupted when MRN is deficient (Mre11 −/− ), or in the context of Mre11 ATLD1 (Fig. 2c) .
We further postulated that CDK activity might influence overall CtIP protein levels. To this end, we determined the impact of the CDK inhibitor roscovitine on CtIP levels. This compound caused a marked reduction in CtIP levels but no impact on Mre11 (Fig. 2d) . We also examined murine fibroblasts homozygous for a CDK2 knockout allele (CDK2 −/− ) 37 . In this case, CtIP levels were modestly lowered relative to controls (Fig. 2d) . The minimal impact of CDK2 deficiency is not unexpected, given the ability of CDK family members to substitute for others when absent 38 . The greater impact of roscovitine is consistent with this notion, as it inhibits the CDK family broadly and would thus reduce substitution by other CDKs 39 .
We conclude that the phosphorylation status of CtIP in unperturbed dividing cells is under control of the Mre11 C terminus. This newly uncovered function appears to govern both CtIP protein levels and interaction with BRCA1.
Mre11 associates with CDK2
That CtIP levels are co-dependent on Mre11 and CDK2 suggests a functional relationship may exist among these factors. Hence, we conducted a series of coimmunoprecipitation experiments to explore the possibility that MRN and CDK2 function together in a multiprotein complex. First, endogenous Mre11 was immunoprecipitated from MEFs, and both CDK2 and cyclin A were observed to coimmunoprecipitate (Fig. 3a) . To address the specificity of the coimmunoprecipitations and a r t i c l e s potential complexes, we blotted for cyclin D1, which is present in G1 and not known to associate with CDK2. Cyclin D1 was not detected in the coimmunoprecipitate fractions ( Fig. 3a) . Conversely, upon precipitation of hemagglutinin (HA)-tagged CDK2 transiently expressed in human cells (HeLa), we detected Mre11, Rad50 and NBS1 (Fig. 3b) .
In addition, when cyclin A was precipitated, Mre11 was present in the coimmunoprecipitation eluate ( Fig. 3c) . Finally, in cells deficient for MRN (Mre11 −/− ), CDK2 maintained association with cyclin A (Fig. 3c) .
Together, these findings indicate that MRN associates in vivo with CDK2 and its S-phase binding partner cyclin A. Next, endogenous Mre11 was immunoprecipitated from CDK2 −/− MEFs to determine whether other CDK family members associate with Mre11. Whereas NBS1 was detected in the coimmunoprecipitation fraction, no CDKs were identified by western blot analysis with an antibody to the highly conserved cyclin binding PSTAIR helix (Fig. 3d) . In addition, cyclin A was not detected. Thus, our coimmunoprecipitations appear to be quite specific, and they support the notion that MRN does not associate globally with CDK-cyclins. We interpret the minimal impact on CtIP levels in CDK2 −/− cells (Fig. 2d) to indicate that an alternative kinase acts without Mre11 interaction. However, we cannot rule out the possibility that either weak interaction occurs below our detection limit or an uncharacterized kinase interacts that is not recognized by the PSTAIRE antibody interacts with Mre11.
Additional coimmunoprecipitations were carried out to directly address the requirement for the Mre11 C terminus. In this case, HAtagged CDK2 was transiently expressed and precipitated from MEFs that expressed both wild-type endogenous Mre11 and either Mre11 C54 or Mre11 ATLD1 from cDNA (Fig. 3e) . Whereas wild-type Mre11 was present in both coimmunoprecipitation eluates, Mre11 molecules with the large tag (Mre11 C54 ) or C-terminal deletion (Mre11 ATLD1 ) were absent. Thus, the in vivo association between CDK2-cyclin A and Mre11 requires an unperturbed Mre11 C terminus.
Direct interaction between Mre11 and CDK2
To determine if Mre11 and CDK2 interact directly, we used the yeast two-hybrid system 40 . When cloned into either configuration of bait and prey plasmid, Mre11 and CDK2 showed a readily npg a r t i c l e s detectable interaction ( Fig. 4a and Supplementary Fig. 4) . Notably, Mre11 ATLD1 reduced the interaction with CDK2 to near background levels (Fig. 4a) . By contrast, Mre11 ATLD1 showed no reduction in the ability to homodimerize, indicating that the C-terminal deletion does not globally affect the Mre11 protein (Fig. 4a) .
We used this system to more precisely define Mre11 requirements and found that deletion of the 26 or 13 C-terminal residues disrupted interaction (Fig. 4b) . Furthermore, we asked whether the Mre11 C terminus alone is sufficient for interaction. In this case, the 76 C-terminal amino acids of Mre11 (Mre11 c76aa ) were expressed in the yeast two-hybrid system, along with CDK2. We found that the final 76 amino acids of Mre11 can interact with CDK2, although with lower apparent affinity than full-length Mre11 (Fig. 4c) .
These studies demonstrate that Mre11 and CDK2 interact directly. Interaction requires the final 13 amino acids of Mre11. Among mammals, this short sequence is well conserved (69% identity between human and mouse) and has a consensus sequence of PFM(N/S)o(S/N)ooRR(N/S)RR (where o denotes hydrophobic residues) ( Supplementary Fig. 5 ).
CtIP DSB repair functions depend on the Mre11 C terminus
Our findings predict that through control of CtIP levels, the C terminus of Mre11 regulates the ability of cells to repair DSBs by homologous recombination. We therefore determined the impact on DSB repair of Mre11 alleles that disrupt CDK2 interaction and cause low CTIP levels. First, we examined repair of a chromosomal DSB by the homologous recombination pathway using a single integrated copy of the DR-GFP reporter plasmid 41 . This construct contains a GFP gene inactivated by insertion of the I-SceI endonuclease recognition site (Fig. 5a) . GFP is reconstructed only after the I-SceIinduced DSB is repaired by homologous recombination, during which an adjacent GFP fragment is used as a template to restore missing sequences. We observed that Mre11 C54 and Mre11 ATLD1 each caused significant defects relative to control (P < 0.05 for both) (Fig. 5a) . Even the short 13-residue deletion caused a similar defect (P < 0.05 for both) (Fig. 5a) .
To address the possibility that disruption of the Mre11 C terminus causes an homologous recombination defect for reasons other than CtIP deficiency, we complemented CtIP through forced overexpression. We transfected Mre11 WT or Mre11 ATLD1 cells containing the DR-GFP reporter with exogenous murine CtIP using the pSport6-CMV expression plasmid. Indeed, CtIP expression caused a significant increase in homologous recombination in Mre11 ATLD1 cells but did not increase homologous recombination above normal in cells expressing wild-type Mre11 (P < 0.05) (Fig. 5b) . Although it was significant, the complementation by CtIP did not fully restore homologous recombination to wild-type levels. This might result from the forcibly expressed protein lacking appropriate posttranslational modifications. We therefore expressed CtIP harboring established phosphomimetic mutations at two consensus CDK sites. Ser326 and Thr843 in Mus musculus (corresponding to Ser327 and Thr847 in humans) were changed to glutamate (CtIP pp ) 19, 22 . This construct complemented the recombination assay with greater apparent efficiency than did wild-type CtIP (Fig. 5b) , although this difference was not statistically significant (P > 0.05). Side-by-side control transfections with a GFP-expressing reporter indicate that ~40% of the cells can be transfected with plasmid (data not shown), and thus the effectiveness of complementation is probably underestimated in these experiments. Therefore, the homologous recombination defect associated with disruption of the Mre11 C terminus is a result of CtIP deficiency. However, a minor contribution by some other function of the Mre11 C terminus cannot be entirely ruled out.
Next, we determined the impact of Mre11 C54 and Mre11 ATLD1 on ionizing radiation sensitivity to assess the overall ability to respond to DSBs. Both mutants showed significant defects relative to controls (P < 0.05) (Fig. 5c) . Finally, to assess DSB resection capacity, we examined immunofluorescent foci induced by DNA damage that were composed of RPA, which coats single-stranded DNA immediately following resection 9 . Consistent with a resection defect, there was a 30% reduction of ionizing radiation-induced RPA foci in Mre11 ATLD1 cells (Fig. 5d) .
Collectively, these studies support the notion that disruption of the Mre11 C terminus causes a CtIP-dependent defect in DSB repair by homologous recombination, resulting from reduced capacity to resect DNA.
DISCUSSION
Here we have demonstrated that the C terminus of Mre11 governs the phosphorylation status and overall levels of the CtIP protein, thereby controlling formation of the S-and G2-phase MRN-CtIP-BRCA1 complex. We find that this same portion of Mre11 interacts directly with CDK2, forming a tripartite subcomplex with S-and G2-specific 19, 20, 22 , our work supports the notion that interaction between Mre11 and CDK2-cyclin A facilitates phosphorylation of CtIP in normally dividing cells. This newly uncovered function of Mre11 serves to control the capacity of cells to initiate resection at DSBs, thereby restricting use of the homologous recombination pathway to phases of the cell cycle when sister chromatids are present ( Fig. 6) .
Classically, MRN is considered to have a central function in the canonical DDR 10 . The complex binds rapidly to DNA ends and then engages in several downstream processes 42, 43 . These include stabilizing the two sides of a DSB in close proximity and processing the ends through the nuclease activities of Mre11 (refs. 6,12) . These functions are encoded by the most highly conserved portions of Mre11 and Rad50, which are apparently present in all terrestrial life forms 44 . The third component is only found in eukaryotes and is less well conserved. This subunit has evolved as a flexible linker thought to transmit information from the Rad50-Mre11 core to binding partners such as the ATM kinase 17, 18 . Notably, this newly uncovered function of the Mre11 C terminus appears to act independently of the previously characterized roles of MRN. Perturbations of the Mre11 C terminus that disrupt interaction with CDK2 and cause CtIP deficiency did not prevent activation of the ATM kinase after exposure to ionizing radiation. This strongly suggests that DDR functions of MRN are intact, as ATM activation requires DSB recognition and conformational alterations by all three MRN components 6, 33, 45 . Like the newly uncovered function of the Mre11 C terminus, the nuclease activities encoded by the Mre11 N terminus (Supplementary Fig. 1 ) also act independently of ATM activation 6 . However, these two functions of Mre11 are separable, as evidenced by normal CtIP levels being present in cells expressing the nuclease-dead Mre11 H129N .
The C terminus of mammalian Mre11 represents a previously uncharacterized domain capable of binding CDK2. This region is conserved among mammals but shows no sequence homology to Mre11 of other evolutionary groups. Despite lack of sequence conservation, Mre11 from eukaryotes all contain a C terminus extending several hundred amino acids beyond the highly conserved N-terminal nuclease domains. In contrast, prokaryotes and archaea, which do not possess eukaryotic-like CDKs, lack an extended Mre11 C terminus 46, 47 . This parallels the evolutionary pattern of the third subunit (NBS1 in mammals), which also arose in eukaryotes and interacts directly with a kinase (ATM in mammals). At present there is no structural information available for the C terminus of eukaryotic Mre11, nor does the sequence contain recognizable domains. We speculate that this portion of Mre11 is a relatively unstructured flexible tether with CDK2 binding capabilities. This would parallel the flexible tethers that have been proposed for NBS1 interactions and are a common strategy for transient protein interactions that allow for varied and intricate conformational changes 18 . The precise structure of the mammalian Mre11-CDK2 interface and the extent to which Mre11 interacts with a CDK family member in other eukaryotes represent important questions for future studies.
Collectively, our findings demonstrate that through control of CtIP, Mre11 and CDK2 provide the molecular switch whereby mammalian cells induce the capacity to catalyze homologous recombination upon entry into S phase (Fig. 6) . Given that CtIP interacts with NBS1, we postulate that the MRN complex serves as a bridge to facilitate the kinase-substrate relationship between CDK2 and CtIP. This occurs in unperturbed dividing cells and is distinct from the roles of MRN in response to DNA damage. Therefore, this newly uncovered relationship between Mre11 and CDK2 represents a fundamental feature of the mammalian cell cycle.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/. Figure 6 Model depicting control of homologous recombination capacity by Mre11. Cells increase the capacity to repair DSBs by homologous recombination upon entry into S phase to take advantage of the presence of sister chromatids, which serve as replication templates during repair.
Here we demonstrate that Mre11 regulates this process by controlling signaling from the core cell-cycle apparatus to the DSB repair machinery. This is accomplished by direct interaction between CDK2-cyclin A and the C terminus of Mre11, which facilitates phosphorylation of CtIP, leading to increased CtIP levels and interaction with BRCA1. This phosphorylation is regulated in the cell cycle by the requirement of CDK2 for S-and G2-specific cyclin A. These events occur during the normal cell cycle and are distinct from the DNA damage response that is initiated upon recognition of DSBs by the MRN complex. (Rad50 and NBS1 are present with Mre11 during interaction with CDK2 but are not shown in the figure for simplicity). 
